Cell Signaling Technology

Product Pathways - Protein Stability

SignalSilence® TRIM27 siRNA I #15157

No. Size Price
15157S 300 µl ( 3 nmol ) ¥3,224.00 现货查询 购买询价
15157 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
TFN Human,

Species cross-reactivity is determined by western blot.

Applications Key: TFN=Transfection,


SignalSilence® TRIM27 siRNA I from Cell Signaling Technology (CST) allows the researcher to specifically inhibit TRIM27 expression using RNA interference, a method whereby gene expression can be selectively silenced through the delivery of double stranded RNA molecules into the cell. All SignalSilence® siRNA products from CST are rigorously tested in-house and have been shown to reduce target protein expression by western analysis.

Quality Control

Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.

Western Blotting

Western Blotting

Western blot analysis of extracts from MCF7 cells transfected with 100 nM SignalSilence® Control siRNA (Unconjugated) #6568 (-) or SignalSilence® TRIM27 siRNA I (+), using TRIM27 (D5S4O) Rabbit mAb #15099 (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower). The TRIM27 (D5S4O) Rabbit mAb confirms silencing of TRIM27 expression, while the β-Actin (D6A8) Rabbit mAb is used as a loading control.

Directions for Use

CST recommends transfection with 100 nM SignalSilence® TRIM27 siRNA I 48 to 72 hours prior to cell lysis. For transfection procedure, follow the protocol provided by the transfection reagent manufacturer. Please feel free to contact CST with any questions on use.

Each vial contains the equivalent of 100 transfections, which corresponds to a final siRNA concentration of 100 nM per transfection in a 24-well plate with a total volume of 300 μl per well.


Tripartite motif containing protein 27 (TRIM27, RFP) is a member of the tripartite motif (TRIM) family whose members contain a RING domain, a B-box, and a coiled-coil region (together called RBCC). TRIM27 was originally discovered as part of an oncogenic DNA rearrangement resulting in a fusion of the amino terminal RBCC region of TRIM27 with the carboxyl terminal kinase domain of the receptor tyrosine kinase Ret (1). Overexpression of TRIM27 induces JNK and p38 MAPK activation as well as apoptosis (2). TRIM27 has been found to have pleiotropic effects including transcriptional repression (3,4), and E3 ligase activity for ubiquitin (5-7), and SUMO (8). TRIM27 was originally found to interact with Enhancer of Polycomb (EPC) and function as a transcriptional repressor (3). Subsequent studies have identified ubiquitin E3 ligase activity in TRIM27 as well as other members of the TRIM family (reviewed in 9). Potential substrates of TRIM27-mediated ubiquitination include class II PI3K-C2β, NOD2, and WASH. Elevated expression of TRIM27 has been observed in several types of cancer, where in some cases it may be a predictor of poor prognosis (10-13).

  1. Takahashi, M. et al. (1988) Mol Cell Biol 8, 1853-6.
  2. Dho, S.H. and Kwon, K.S. (2003) J Biol Chem 278, 31902-8.
  3. Shimono, Y. et al. (2000) J Biol Chem 275, 39411-9.
  4. Bloor, A.J. et al. (2005) Oncogene 24, 6729-36.
  5. Cai, X. et al. (2011) Proc Natl Acad Sci U S A 108, 20072-7.
  6. Zurek, B. et al. (2012) PLoS One 7, e41255.
  7. Hao, Y.H. et al. (2013) Cell 152, 1051-64.
  8. Chu, Y. and Yang, X. (2011) Oncogene 30, 1108-16.
  9. Meroni, G. and Diez-Roux, G. (2005) Bioessays 27, 1147-57.
  10. Tezel, G.G. et al. (2009) Pathol Res Pract 205, 403-8.
  11. Tsukamoto, H. et al. (2009) Cancer Sci 100, 1895-901.
  12. Iwakoshi, A. et al. (2012) Pathol Int 62, 324-30.
  13. Zoumpoulidou, G. et al. (2012) J Natl Cancer Inst 104, 941-52.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!


Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

SignalSilence is a registered trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :